Showing 9 of 9 recruiting trials for “benign-concentric-annular-macular-dystrophy”
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
RecruitingNCT07125040 ↗
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
RecruitingNCT06503367 ↗
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
RecruitingNCT06805474 ↗
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
RecruitingNCT06354790 ↗
Natural History Study of Children With LAMA2-related Dystrophies
RecruitingNCT06924125 ↗
Spanish Natural History Study for LAMA2 Muscular Dystrophy
RecruitingNCT05809635 ↗
Study of BEST1 Vitelliform Macular Dystrophy
RecruitingNCT01403402 ↗
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
RecruitingNCT00138931 ↗
Genetics of Cardiovascular and Neuromuscular Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →